Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-2963-2020

Lactate Dehydrognease P-L, (UV), Catalog Number LD3818 - Product Usage: device intended for the quantitative in vitro determination of Lactate Dehydrogenase (LD) activity in serum and plasma. This product is suitable for use on the RX series instruments which includes the RX daytona and RX imola.

Publicado el 23 de septiembre de 2020 · Inicio del retiro: 11 de agosto de 2020

Resumen

FDA registra el retiro Z-2963-2020 de dispositivos médicos de Clase II, publicado el 23 de septiembre de 2020 e iniciado el 11 de agosto de 2020. Empresa responsable: Randox Laboratories Ltd.; Estado: Finalizado; Cantidad reportada: 4; Lote: GTIN: 05055273204117; Lot Numbers: 511979. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Randox Laboratories Ltd.
Distribuidor
US Nationwide distribution including in the states of WV, and Puerto Rico.
Lote
GTIN: 05055273204117; Lot Numbers: 511979
Clasificación de riesgo
Class II
Área (FDA)
device
País
Ireland

Retiros relacionados

Preguntas sobre este retiro

¿Lactate Dehydrognease P-L, (UV), Catalog Number LD3818 - Product Usage: device intended for the quantitative in vitro determination of Lactate Dehydrogenase (LD) activity in serum and plasma. This product is suitable for use on the RX series instruments which includes the RX daytona and RX imola. fue retirado del mercado?

Sí. FDA publicó el retiro Z-2963-2020 el 23 de septiembre de 2020. Peligro reportado: An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter